A recent article in JAMA Psychiatry highlighted concerns over stimulant use and abuse when prescribed to treat adults with attention deficit hyperactivity disorder (ADHD) in the United States. The ...

The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of ...

Add Yahoo as a preferred source to see more of our stories on Google. Stimulant drugs and another medication – atomoxetine – appear to be the best treatment for managing symptoms of ADHD, a study ...

The FDA has approved Simtriyo (centanafadine) as the first norepinephrine, dopamine, serotonin reuptake inhibitor for adult and pediatric ADHD.

Allison Burk’s teenage daughter struggled with uncontrolled emotions, a shrinking attention span, and a growing tendency to procrastinate. A family doctor suggested ADHD testing, which led to an ...

Simtriyo was just approved by the U.S. Food and Drug Administration to treat attention-deficit/hyperactivity disorder (ADHD) in children, teens, and adults. The ADHD ...

Attention deficit/hyperactivity disorder—also known as ADHD—is typically thought of as a childhood condition. But more adults are realizing that their struggles with attention, focus and restlessness ...

ADHD, which stands for attention-deficit hyperactivity disorder, is a neurodevelopmental disorder that’s typically diagnosed in children. But according to data from the National Center for Health ...

An 18-year follow-up study published in Psychiatry Research provides evidence that children diagnosed with ...

Kids with attention-deficit/hyperactivity disorder may grow up to be adults with ADHD. Although symptoms are generally more common in children (with approximately 8.4 ...

With everything there is to juggle in life, it’s easy to assume that everyone experiences that sinking-in-quicksand feeling as they navigate another busy day. But if you find this feeling is paired ...